provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeHealth ConditionsPsoriasis

Can Ozempic Treat Psoriasis?

Brian Clista, MDMaria Robinson, MD, MBA
Written by Brian Clista, MD | Reviewed by Maria Robinson, MD, MBA
Published on June 18, 2025

Key takeaways:

  • Ozempic (semaglutide) is an injectable medication that’s FDA-approved to treat several conditions. Ozempic is also being used off-label to treat psoriasis. 

  • Researchers believe Ozempic can help treat psoriasis and other autoimmune conditions by reducing inflammation. 

  • It’s not clear if Ozempic works for most people with psoriasis. Future research will show whether or not Ozempic should be part of psoriasis treatment. 

Psoriasis on the nape of a woman's neck.
Egor Kulinich/iStock via Getty Images Plus

Ozempic (semaglutide) is an injectable medication that’s FDA-approved to treat Type 2 diabetes. It’s also used to lower the risk of heart attacks, strokes, and complications from kidney disease in people with Type 2 diabetes. 

Ozempic is also being prescribed “off-label” to treat other medical conditions, including surprising ones like psoriasis. But how can a medication like semaglutide help your skin? Here’s what the research shows about Ozempic and psoriasis.

Can Ozempic treat psoriasis?

Ozempic (semaglutide) isn’t FDA-approved to treat psoriasis. But there’s some evidence that Ozempic may help improve psoriasis symptoms. 

Researchers first noticed that people with psoriasis who were taking Ozempic to treat Type 2 diabetes were reporting improvements in their psoriasis symptoms. Other studies with larger groups of people showed similar results.

But these studies only showed a link between Ozempic and psoriasis. They couldn’t directly show that Ozempic was the reason for the improvements in people’s skin. 

So far, small clinical trials have shown that Ozempic can improve psoriasis symptoms. But these trials weren’t large enough to show if it works for most people. Also, the people in these trials had both psoriasis and Type 2 diabetes. So, it’s not clear if Ozempic can offer the same benefit to people who have psoriasis but not Type 2 diabetes.

GoodRx icon
  • Skyrizi for psoriasis: Our Skyrizi guide has everything you need to know about this psoriatic arthritis treatment.

  • Psoriasis doesn’t look the same on everyone. These pictures show how psoriasis rashes can look different depending on your skin tone and the parts of your body.

  • Affording psoriasis treatment can be tricky. Here’s which psoriasis medications are covered by Medicare.

Larger clinical trials are needed to help answer these questions. 

How does Ozempic work for psoriasis treatment?

Psoriasis is an autoimmune condition that causes skin inflammation. Ozempic is best known for regulating blood sugar. But it can also help lower inflammation. This could help control psoriasis.

Researchers believe Ozempic lowers inflammation by: 

It’s also possible that the weight loss caused by Ozempic may also contribute to improved psoriasis in some people. Many people with psoriasis are also considered overweight or obese. And some studies show that weight loss can help improve psoriasis symptoms.

How effective is Ozempic at treating psoriasis?

It’s not clear how well Ozempic works to treat psoriasis. There are only a few small clinical trials looking at Ozempic for the treatment of psoriasis. 

In one of these trials, people had big improvements in their psoriasis area and severity index (PASI) scores and dermatology life quality index (DLQI) scores. These scores measure how many symptoms people experience over time and how those symptoms affect their daily lives. 

In another study, people taking Ozempic to treat Type 2 diabetes saw their PASI and DLQI scores improve by 98% and 95%, respectively. 

These results are encouraging, but more research is needed to know if Ozempic really works well for psoriasis treatment.

Who can use Ozempic for psoriasis?

Experts are still trying to figure out who may benefit from Ozempic as a psoriasis treatment. 

So far, most of the research has looked at people who have both Type 2 diabetes and psoriasis. If you’re thinking about taking Ozempic for diabetes, it may also help ease some of your psoriasis symptoms. It’s not yet clear if it works the same for people who don’t have diabetes.

In general, Ozempic is safe for most people. But you can’t take Ozempic if you: 

  • Have a history of certain types of thyroid cancer, or thyroid cancer runs in your family

  • Have multiple endocrine neoplasia type 2 (MEN 2)

  • Have a history of pancreatitis

  • Are pregnant

What are the risks of taking Ozempic to treat psoriasis?

Like any medication, Ozempic can cause side effects. The most common side effects you might experience from using semaglutide include:

Rarely, Ozempic can also cause:

It’s not clear if taking Ozempic for psoriasis can lead to other side effects or increase the risks of other medical problems. 

Can you combine Ozempic with other psoriasis treatments?

Yes, you can combine Ozempic with other psoriasis treatments. In fact, since Ozempic isn’t FDA-approved to treat psoriasis, it should be used along with other psoriasis treatments.

Your healthcare team may recommend Ozempic if you also have Type 2 diabetes and your psoriasis isn’t responding well to other treatments. 

The bottom line

Some people who have both Type 2 diabetes and psoriasis have seen their skin improve while taking Ozempic for diabetes. Ozempic may improve psoriasis symptoms by lowering inflammation and improving blood sugar control. Ozempic isn’t an FDA-approved psoriasis treatment. It’s not clear if Ozempic will work for everyone with psoriasis. But your healthcare team may recommend Ozempic for psoriasis if you also have Type 2 diabetes, especially if other psoriasis therapies aren’t working.

why trust our exports reliability shield

Why trust our experts?

Brian Clista, MD
Written by:
Brian Clista, MD
Dr. Clista is a board-certified pediatrician who works in private practice in Pittsburgh, Pennsylvania. He previously served as a National Health Service Corporation Scholar in the inner city of Pittsburgh for 11 years.
Patricia Pinto-Garcia, MD, MPH
Patricia Pinto-Garcia, MD, MPH, is a medical editor at GoodRx. She is a licensed, board-certified pediatrician with more than a decade of experience in academic medicine.
Maria Robinson, MD, MBA
Maria Robinson, MD, MBA, is a board-certified dermatologist and dermatopathologist who has practiced dermatology and dermatopathology for over 10 years across private practice, academic, and telehealth settings. She is a fellow of the American Academy of Dermatology and the American Society of Dermatopathology.
View All References (14)

Costanzo, G., et al. (2021). Two birds one stone: semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient. Endocrinology, Diabetes & Metabolism Case Reports.

Feier, C. V. I., et al. (2024). Assessment of thyroid carcinogenic risk and safety profile of GLP1-RA semaglutide (ozempic) therapy for diabetes mellitus and obesity: A systematic literature review. International Journal of Molecular Sciences.

Haran, K., et al. (2024). Impact of GLP-1 receptor agonists on psoriasis and cardiovascular comorbidities: A narrative review. Psoriasis: Targets and Therapy.

Jensen, P., et al. (2016). Psoriasis and obesity. Dermatology.

Malavazos, A. E., et al. (2023). Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and Type-2 diabetes. Endocrinology, Diabetes & Metabolism Case Reports.

Monda, S. (2024). Dermatology Life Quality Index (DLQI). DermNet.

Novo Nordisk. (2017). Ozempic (semaglutide) injection, for subcutaneous use [package insert].

Oakley, A. (2009). PASI score. DermNet.

Petković-Dabić, J., et al. (2025). Effects of semaglutide treatment on psoriatic lesions in obese patients with Type 2 diabetes mellitus: An open-label, randomized clinical trial. Biomolecules.

Rohn, T. V., et al. (2022). Inflammation in obesity, diabetes, and related disorders. Immunity.

Stocum, L. (2022). Study: The link between diabetes, obesity and psoriasis treatment. Drug Topics.

Vilarrasa, E., et al. (2024). Glucagon-like peptide-1 agonists for treating obesity in patients with immune-mediated skin diseases. Actas Dermo-Sifiliográficas.

Yaribeygi, H., et al. (2024). Anti-inflammatory benefits of semaglutide: State of the art. Journal of Clinical and Translational Endocrinology.

Yasir, M., et al. (2023). Multiple endocrine neoplasias type 2. StatPearls.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Get the facts on Psoriasis.

Sign up for our newsletter to get expert tips on condition management and prescription savings.

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

Related Articles